Abvc Biopharma (ABVC) Share-based Compensation (IS) (2018 - 2026)
Abvc Biopharma (ABVC) posted Share-based Compensation (IS) of $507,041 for Q2 2026, down 25.7% from $682,345 a year earlier but up 377.0% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Share-based Compensation (IS) (2018 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation (IS) at Abvc Biopharma was $1.34 million, down 46.2% year-over-year; for FY2025, it was $1.73 million, down 13.4% from FY2024.
- Annual Share-based Compensation (IS) shows a four-year compound annual growth rate of -24.5% (FY2021 to FY2025).
- In prior years, Abvc Biopharma's Share-based Compensation (IS) was $2 million in FY2024 (+271.8%), $536,648 in FY2023 (-92.4%), $7.04 million in FY2022 (+32.6%) and $5.31 million in FY2021.
- Quarterly Share-based Compensation (IS) has run from a low of $48,773 in Q1 2025 to a high of $4.69 million in Q1 2022 over five years.
- On a year-over-year basis, Share-based Compensation (IS) increased in three of the last six quarters, with growth averaging 55.2%.
- The strongest year-over-year quarter for Share-based Compensation (IS) in the past five years was Q3 2023, with growth of 262.2%; the weakest was Q1 2025, with a decline of 78.4%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Abvc Biopharma | 27.31 Mn | 29.30 Mn | - | 507,041.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 507,041.00 |
| Mar 31, 2026 | 106,287.00 |
| Jun 30, 2025 | 682,345.00 |
| Mar 31, 2025 | 48,773.00 |
| Dec 31, 2024 | 1.54 Mn |
| Sep 30, 2024 | 225,740.00 |
| Jun 30, 2024 | 225,740.00 |
| Mar 31, 2024 | 225,740.00 |
| Dec 31, 2023 | 536,648.00 |
| Sep 30, 2023 | 817,740.00 |
| Jun 30, 2023 | 225,740.00 |
| Dec 31, 2022 | 1.89 Mn |
| Sep 30, 2022 | 225,740.00 |
| Jun 30, 2022 | 225,740.00 |
| Mar 31, 2022 | 4.69 Mn |
| Mar 31, 2019 | 28,800.00 |
| Dec 31, 2018 | 5,399.00 |
| Mar 31, 2018 | 155,400.00 |
API Access
Abvc Biopharma Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();